OWLO Secures $2.5M Pre-Seed for Next-Gen 3D Imaging Microscopy

OWLO, a company specializing in next-generation microscopy for healthcare, has secured $2,500,000 in funding from investors. The capital infusion will support the company's mission to transform medical imaging and research through its innovative technology. This investment marks a significant step for the spin-off from CNRS lab Institut Langevin as it progresses in bringing its solutions to market. At the core of OWLO's offering is a unique microscopy technology that provides real-time 3D imaging in a non-invasive manner. This innovation, powered by artificial intelligence for image analysis, aims to make visible and quantifiable what was previously unseen in biological samples. By enabling new levels of observation, OWLO seeks to change both research methodologies and medical practices. The company's initial application focuses on Assisted Reproductive Technologies (ART). Current ART procedures face a significant challenge, with approximately 75% of embryo transfers failing. This often leads to prolonged, expensive, and emotionally taxing processes for individuals. OWLO's technology introduces a novel approach to examine embryos, providing new indicators to predict viability before implantation, thereby aiming to improve procedure efficiency and reduce associated costs. This $2,500,000 investment underscores confidence in OWLO's technological potential and its proposed impact on critical healthcare sectors. The funds will be strategically deployed to accelerate the development and refinement of its microscopy platform. This includes expanding its research and development capabilities, strengthening its engineering team, and preparing for the commercialization of its solutions. Looking ahead, OWLO plans to leverage this capital to drive its growth initiatives and expand its reach within the healthcare industry. The company anticipates its technology will not only significantly enhance outcomes in ART but also pave the way for future applications across a broader spectrum of medical diagnostics and biological research, ultimately contributing to more effective and less invasive healthcare solutions.